跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ebola vaccine
首页
药物
ebola vaccine
ebola vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NANOPARTICLE VACCINES WITH NOVEL STRUCTURAL COMPONENTS
EP 3807210 A4
申请人: SCRIPPS RESEARCH INST
优先权: 2018
CN
EP
US
WO
7 件公开
VLP-based bivalent Ebola vaccines and methods of making and using same
US 11129886 B2
申请人: CHILDRENS HOSPITAL MED CT
优先权: 2018
US
5 件公开
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use
US 10576141 B2
申请人: BAVARIAN NORDIC AS
优先权: 2014
CN
US
3 件公开
Ebola virus and Marburg virus glycoprotein mucin-like domain replacement expression system used as new vaccine approaches
US 11400149 B2
申请人: UNIV MANITOBA
优先权: 2017
CN
US
2 件公开
Generation of virus-like particles and use as panfilovirus vaccine
US 7682618 B2
申请人: US ARMY
优先权: 2005
US
2 件公开
US 2006099225 A1
申请人: BAVARI SINA
优先权: 2005
US
US 2011280904 A1
申请人: BAVARI SINA
优先权: 2011
US
Dendritic Cell-Targeting Universal Vaccine for Influenza Infection
US 20240181045 A1
申请人: UNIV MANITOBA
优先权: 2020
US
2 件公开
Adenovirus vector with multiple expression cassettes
US 6544780 B1
申请人: GENPHAR INC
优先权: 2000
US
Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
US 2004057967 A1
申请人: BAVARI SINA
优先权: 2002
US
Generation of virus-like particles and use as panfilovirus vaccines
US 2010143409 A1
申请人: BAVARI SINA
优先权: 2009
US
EBOLA VIRUS LIPOSOME VACCINE
WO 2012050193 A1
申请人: UNIV SAITAMA MEDICAL
优先权: 2010
WO
第 1 / 4 页
上一页
下一页
药物
反馈